Stereotactic Radiotherapy for Wet AMD (STAR)

Summary

Stereotactic Radiotherapy for Wet AMD (STAR) is a clinical trial^[1].

Key Facts

• Stereotactic Radiotherapy for Wet AMD (STAR) is in the country of United Kingdom^[2].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s instance of is recorded as clinical trial^[3].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s start time is recorded as +2014-12-31T00:00:00Z^[4].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s end time is recorded as +2021-10-31T00:00:00Z^[5].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s main subject is recorded as macular degeneration^[6].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s number of participants is recorded as {'unit': '1', 'amount': '+411'}^[7].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s title is recorded as StereoTactic Radiotherapy for Wet Age-Related Macular Degeneration (STAR): A Randomised, Double-masked, Sham-controlled, Clinical Trial Comparing Low-voltage X-ray Irradiation With as Needed Ranibizumab, to as Needed Ranibizumab Monotherapy.^[8].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s short name is recorded as STAR^[9].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+50'}^[10].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s ClinicalTrials.gov ID is recorded as NCT02243878^[11].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+110'}^[12].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s research intervention is recorded as ranibizumab^[13].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s clinical trial phase is recorded as phase III clinical trial^[14].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s research site is recorded as Royal Hallamshire Hospital^[15].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s research site is recorded as Stoke Mandeville Hospital^[16].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s research site is recorded as Heart of England NHS Foundation Trust^[17].
• Stereotactic Radiotherapy for Wet AMD (STAR)'s study type is recorded as interventional study^[18].